Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Atomoxetine Hydrochloride

    Client Email Product

    Atomoxetine Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    37
    US DMFs Filed

    US DMFs Filed

    17
    CEP/COS Certifications

    CEP/COS Certifications

    10
    JDMFs Filed

    JDMFs Filed

    6
    Other Certificates

    Other Certificates

    13
    Other Suppliers

    Other Suppliers

    22
    API REF. PRICE (USD / KG)
    878

    API Market Place

    5
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    77
    Europe

    Europe

    90
    Canada

    Canada

    69
    Australia

    Australia

    14
    South Africa

    South Africa

    43
    Uploaded Dossiers

    Uploaded Dossiers

    53
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    385.00

    Annual Reports

    451.00

    FDF Market Place

    2
    EXCIPIENTS
    41
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    17
    REF STANDARD

    EDQM

    4

    USP

    5

    JP

    0

    Other Listed Suppliers

    9
    SERVICES
    1
    left grey arrow
    right gray arrow
    • CAPSULE;ORAL - EQ 100MG BASE
    • CAPSULE;ORAL - EQ 10MG BASE
    • CAPSULE;ORAL - EQ 18MG BASE
    • CAPSULE;ORAL - EQ 25MG BASE
    • CAPSULE;ORAL - EQ 40MG BASE
    • CAPSULE;ORAL - EQ 60MG BASE
    • CAPSULE;ORAL - EQ 80MG BASE
    Full View ScreenFull Screen View
    Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109
    Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109

    https://apnimed.com/apnimed-announces-positive-topline-results-for-mariposa-trial-of-ad109/

    PRESS RELEASE
    17 Oct 2022
    Share Share
    Apnimed to Participate in the Annual Needham Biotech Company Virtual 1x1 Forum
    Apnimed to Participate in the Annual Needham Biotech Company Virtual 1x1 Forum

    https://www.businesswire.com/news/home/20221012005118/en

    BUSINESSWIRE
    12 Oct 2022
    Share Share
    New Data Show Meaningful Improvements for AD504 in Obstructive Sleep Apnea
    New Data Show Meaningful Improvements for AD504 in Obstructive Sleep Apnea

    https://www.businesswire.com/news/home/20220602005151/en

    BUSINESSWIRE
    02 Jun 2022
    Share Share
    OWP Pharma Announces IND Authorization for the 1st-Ever Oral Liquid Formulation
    OWP Pharma Announces IND Authorization for the 1st-Ever Oral Liquid Formulation

    https://www.globenewswire.com/news-release/2021/11/17/2336301/0/en/OWP-Pharmaceuticals-Announces-IND-Authorization-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorde.html

    GLOBENEWSWIRE
    17 Nov 2021
    Share Share
    Apnimed sees positives in new sleep apnea drug data
    Apnimed sees positives in new sleep apnea drug data

    https://www.fiercebiotech.com/biotech/apnimed-sees-positives-midstage-data-for-its-attempt-at-drugging-sleep-apnea-problem

    Ben Adams FIERCEBIOTECH
    14 Oct 2021
    Share Share
    OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid
    OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid

    https://www.globenewswire.com/news-release/2021/04/22/2215011/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disord.html

    GLOBENEWSWIRE
    22 Apr 2021
    Share Share
    Dr. Reddys Labs Generic Atomoxetine Hydrochloride Receives Approval In US
    Dr. Reddys Labs Generic Atomoxetine Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090609

    FDA
    27 Feb 2018
    Share Share
    Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents
    Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents

    https://www.statnews.com/2017/08/16/eli-lilly-canada-patents-zyprexa-strattera/

    E. RICHARD GOLD STAT
    17 Aug 2017
    Share Share
    Stampeding generics expected to trample Lilly's now-off-patent med Strattera
    Stampeding generics expected to trample Lilly's now-off-patent med Strattera

    http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others

    Eric Sagonowsky FIERCE PHARMA
    01 Jun 2017
    Share Share
    FDA approves first generic Strattera for the treatment of ADHD
    FDA approves first generic Strattera for the treatment of ADHD

    http://www.prnewswire.com/news-releases/fda-approves-first-generic-strattera-for-the-treatment-of-adhd-300465740.html

    PR NEWSWIRE
    30 May 2017
    Share Share
    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers

    http://www.fiercepharma.com/pharma/generics-set-to-undercut-blockbusters-from-merck-novartis-bms-2017

    Eric Sagonowsky FIERCE PHARMA
    18 Jan 2017
    Share Share
    Eli Lilly targets sales force for job cuts in wake of Alzheimer's failure
    Eli Lilly targets sales force for job cuts in wake of Alzheimer's failure

    http://www.fiercepharma.com/pharma/eli-lilly-targets-salesforce-for-job-cuts-wake-alzheimer-s-failure

    Tracy Staton FIERCE PHARMA
    07 Dec 2016
    Share Share
    Shire launches long-acting ADHD drug Intuniv in UK
    Shire launches long-acting ADHD drug Intuniv in UK

    http://www.pmlive.com/pharma_news/shire_launches_long-acting_adhd_drug_intuniv_in_uk_951910?

    Phil Taylor PM LIVE
    09 Mar 2016
    Share Share
    Lilly falls short of analyst forecasts with 2016 guidance on the 'weaker end'
    Lilly falls short of analyst forecasts with 2016 guidance on the 'weaker end'

    http://www.fiercepharma.com/story/lilly-falls-short-analyst-forecasts-2016-guidance-weaker-end/2016-01-05

    Carly Helfand FIERCE PHARMA
    05 Jan 2016
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Health Canada issues “stronger, clearer” warnings about suicide risks linked to ADHD drugs
    Health Canada issues “stronger, clearer” warnings about suicide risks linked to ADHD drugs

    http://www.thestar.com/news/canada/2015/03/30/health-canada-issues-stronger-clearer-warnings-about-suicide-risks-linked-to-adhd-drugs.html

    David Bruser And Jesse McLean THE STAR
    03 Apr 2015
    Share Share
    ADHD Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks
    ADHD Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52759a-eng.php

    HEALTHY CANADIANS
    01 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    View Presentation

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search